VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$11.59
+0.35%Aug 24, 2026, 06:15 UTC
Vicore Pharma announced it will present new data on its buloxibutid program at the European Respiratory Society Congress 2026 in Barcelona, Spain, September 5-9, 2026.
Source: